Mediastinal Staging for Lung Cancer Journal Articles

abstract

• Staging of the mediastinal and hilar lymph nodes plays a crucial role in identifying the best treatment option for patients with confirmed or suspected lung cancer and, in many cases, can simultaneously confirm a diagnosis of cancer. Noninvasive modalities, such as computed tomography (CT), positron emission tomography (PET) and PET‐CT, are an important first step in this assessment. Ultimately, invasive staging is frequently required to confirm or rule out the presence of metastatic disease within the lymph nodes. The present focused review describes and compares noninvasive and invasive modalities for mediastinal staging in lung cancer.

authors

• Gelberg, Jacob
• Grondin, Sean
• Tremblay, Alain

status

• published 

publication date

• January 2014

has subject area

• Endoscopic Ultrasound-Guided Fine Needle Aspiration (MeSH)
• Humans (MeSH)
• Lung Neoplasms (MeSH)
• Lymph Node Excision (MeSH)
• Lymph Nodes (MeSH)
• Lymphatic Metastasis (MeSH)
• Mediastinoscopy (MeSH)
• Mediastinum (MeSH)
• Neoplasm Staging (MeSH)
• Positron-Emission Tomography (MeSH)
• Respiratory System (Science Metrix)
• Tomography, X-Ray Computed (MeSH)

published in

• Canadian Respiratory Journal  Journal

keywords

• Endoscopic Ultrasound-Guided Fine Needle Aspiration
• Humans
• Lung Neoplasms
• Lymph Node Excision
• Lymph Nodes
• Lymphatic Metastasis
• Mediastinoscopy
• Mediastinum
• Neoplasm Staging
• Positron-Emission Tomography
• Tomography, X-Ray Computed

Digital Object Identifier (DOI)

• 10.1155/2014/890108

start page

• 159

end page

• 161

volume

• 21

issue

• 3